Shareholders Xinkang Cheng and Xincheng Longcheng of Pharmaron Beijing (03759) plan to jointly reduce their shareholding by approximately 26.67 million shares.

Pharmaron Beijing (03759) announced that the company recently received a "Share Reduction Plan Notification Letter" from its shareholder, Shenzhen Xinzhong Kangcheng Investment Partnership Enterprise (Limited Partnership) ("Xinzhong Kangcheng") and its concerted action person, Shenzhen Xinzhong Longcheng Investment Partnership Enterprise (Limited Partnership) ("Xinzhong Longcheng"), who hold more than 5% of the company's shares. Xinzhong Kangcheng holds 223,488,310 shares of the company (approximately 12.57% of the total share capital), and plans to reduce its shares by no more than 8,890,977 shares (0.50% of the total share capital) through centralized bidding, block trading, or other legal means recognized by the Shenzhen Stock Exchange within 3 months after the disclosure of this announcement (by December 8, 2025). Xinzhong Longcheng holds 28,498,500 shares of the company (approximately 1.60% of the total share capital), and plans to reduce its shares by no more than 17,781,955 shares (1% of the total share capital) within 3 months after the disclosure of this announcement (by December 8, 2025) through centralized bidding, block trading, or other legal means recognized by the Shenzhen Stock Exchange.